7-methoxy-4-methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione
95%
- Product Code: 82665
CAS:
130477-45-1
| Molecular Weight: | 220.22 g./mol | Molecular Formula: | C₁₁H₁₂N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD31001936 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural similarity to benzodiazepine derivatives. It is often investigated for its potential therapeutic effects, particularly in the treatment of neurological and psychiatric disorders. Researchers explore its application as a precursor or intermediate in the synthesis of compounds that may exhibit anxiolytic, sedative, or muscle relaxant properties. Additionally, its unique structure makes it a candidate for studying interactions with GABA receptors, which are critical in modulating brain activity. The compound is also of interest in drug development for its potential to improve the efficacy and safety profile of benzodiazepine-like drugs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $213.79 |
+
-
|
| 0.250 | 10-20 days | $388.71 |
+
-
|
| 1.000 | 10-20 days | $777.42 |
+
-
|
7-methoxy-4-methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural similarity to benzodiazepine derivatives. It is often investigated for its potential therapeutic effects, particularly in the treatment of neurological and psychiatric disorders. Researchers explore its application as a precursor or intermediate in the synthesis of compounds that may exhibit anxiolytic, sedative, or muscle relaxant properties. Additionally, its unique structure makes it a candidate for studying interactions with GABA receptors, which are critical in modulating brain activity. The compound is also of interest in drug development for its potential to improve the efficacy and safety profile of benzodiazepine-like drugs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :